Brief: Anthera announces positive results from the extension period of the solution study of Sollpura
29/03/2017 21:05
March 29 (Reuters) - Anthera Pharmaceuticals Inc ANTH.O
* Anthera announces positive results from the extension
period of the solution study of Sollpura
* Anthera -Plans to initiate a phase 3 trial, result in 1H
2017, with topline data anticipated at end of 2017 or early 2018
Source text for Eikon: ID:nGNXNSEXLa
Further company coverage: ANTH.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Anthera Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Micron, Darden, Kroger, American Outdoor
Brief: Anthera Pharma's Board Approves Personnel Reorganization Plan
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Netflix, BlueLinx, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, BlueLinx, Orexigen, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Orexigen, Goldman